ResearcherKarolinska InstitutetActive in the last 2 years
Beate Gündel
Matched on ORCID iD 0000-0003-2250-7104; OpenAlex author ID A5017182288. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells. Co-author DOI 10.3390/ijms25179369↗
- 3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.tranon.2021.101107↗
- Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models. Co-author DOI 10.3389/fcell.2021.741162↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rainer Lothar Heuchel · 3 shared papers, 2021–2024 · strength 0.57
- Paper The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity… DOI 10.3390/ijms25179369↗
- Paper Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models. DOI 10.3389/fcell.2021.741162↗
- Paper 3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenoc… DOI 10.1016/j.tranon.2021.101107↗
- Matthias J. Löhr · 3 shared papers, 2021–2024 · strength 0.57
- Paper The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity… DOI 10.3390/ijms25179369↗
- Paper Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models. DOI 10.3389/fcell.2021.741162↗
- Paper 3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenoc… DOI 10.1016/j.tranon.2021.101107↗
- Xinyuan Liu · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.